Research Article

Effect of Repetitive Glucose Spike and Hypoglycaemia on Atherosclerosis and Death Rate in Apo E-Deficient Mice

Table 2

Daily plasma glucose profile of each group.

Control groupGlucose groupGlucose + ipragliflozin groupInsulin groupGlucose + insulin group

Day 18
 Glucose level (mmol/L) after first administration
  0 min11.9 ± 0.511.7 ± 0.413.5 ± 0.313.0 ± 0.312.9 ± 0.3
  15 min12.3 ± 0.518.0 ± 0.516.9 ± 0.414.3 ± 0.6#†21.8 ± 0.8
  30 min13.7 ± 0.615.6 ± 0.716.1 ± 0.515.1 ± 0.418.9 ± 1.0
  60 min12.8 ± 0.712.4 ± 0.612.8 ± 0.413.5 ± 0.414.4 ± 0.5
  120 min10.6 ± 0.410.3 ± 0.410.0 ± 0.212.2 ± 0.311.9 ± 0.3
 Glucose level (mmol/L) after second administration
  0 min9.9 ± 0.410.4 ± 0.310.2 ± 0.411.0 ± 0.311.1 ± 0.2
  15 min10.5 ± 0.417.4 ± 0.415.4 ± 0.411.2 ± 0.3#†19.3 ± 0.8
  30 min11.4 ± 0.513.6 ± 0.712.6 ± 0.712.7 ± 0.514.3 ± 1.0
  60 min10.5 ± 0.610.8 ± 0.39.7 ± 0.310.7 ± 0.411.6 ± 0.3
  120 min9.2 ± 0.58.5 ± 0.28.8 ± 0.610.0 ± 0.411.0 ± 0.2

Day 102
 Glucose level (mmol/L) after first administration
  0 min10.3 ± 0.410.5 ± 0.512.3 ± 0.411.2 ± 0.211.6 ± 0.4
  15 min10.4 ± 0.618.0 ± 0.416.0 ± 0.711.8 ± 0.2#†17.9 ± 0.6
  30 min11.3 ± 0.515.1 ± 0.614.4 ± 0.713.2 ± 0.315.3 ± 0.5
  60 min10.8 ± 0.612.6 ± 0.611.8 ± 0.511.7 ± 0.313.0 ± 0.3
  120 min10.0 ± 0.29.6 ± 0.310.5 ± 0.410.9 ± 0.311.5 ± 0.2
 Glucose level (mmol/L) after second administration
  0 min8.7 ± 0.38.8 ± 0.49.8 ± 0.310.8 ± 0.210.2 ± 0.4
  15 min10.4 ± 0.416.5 ± 0.515.2 ± 0.811.0 ± 0.4#†18.1 ± 0.8
  30 min11.3 ± 0.512.5 ± 0.612.7 ± 0.612.2 ± 0.414.4 ± 0.9
  60 min10.0 ± 0.410.9 ± 0.511.0 ± 0.510.8 ± 0.611.8 ± 0.5
  120 min9.2 ± 0.49.1 ± 0.39.5 ± 0.310.2 ± 0.310.6 ± 0.3

Data are mean ± SEM. versus control, # versus glucose, versus ipragliflozin, and versus insulin.
Mice were provided with water (control group, insulin group) or glucose (glucose group, glucose + ipragliflozin group, and glucose + insulin group) by oral gavage twice a day (9:00 AM: first administration and 4:00 PM: second administration).